This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Friedl, A. Articles by Jordan, V. C. Search for Related Content PubMed PubMed Citation Articles by Friedl, A. Articles by Jordan, V. C.

Enhanced Growth of an Estrogen Receptor-negative Endometrial Adenocarcinoma by Estradiol in Athymic Mice¹

Departments of Human Oncology [A. F., M. M. G., J. P., V. C. J.] and Obstetrics and Gynecology [D. A. B.], University of Wisconsin, Madison, Wisconsin 53792

The aim of this study was to investigate the effects of estradiol and tamoxifen (TAM) on the growth of human endometrial carcinomas in athymic mice. Tissues from primary tumors were implanted into estradiol-treated mice. In passage 2, animals were treated with (a) placebo, (b) estradiol, (c) estradiol plus TAM, and (d) TAM alone. The size of the tumors was measured weekly. Estrogen receptors (ER) were determined with the dextran-coated charcoal method and/or ER enzyme-linked immunoassay. Progesterone receptors were measured with the dextrancoated charcoal technique. Of 16 primary tumors, 2 grew in the athymic mice and were studied further. Tumor EL was positive for ER (145 fmol/mg protein) and progesterone receptors (993 fmol/mg protein). Tumor EL in passage 2 was not significantly stimulated by estradiol, but was stimulated by a combination of estradiol and TAM. Treatments (estradiol, estradiol plus TAM, or TAM) all increased tumor growth in passage 3. Tumor BR and a metastasis BR-MET were ER and progesterone receptor negative, applying dextran-coated charcoal, ER enzyme-linked immunoassay, and immunocytochemistry. The BR and BR-MET cells contain the complete ER gene but do not express any measurable amounts of ER mRNA as quantitated by Northern blot analysis, using a complete ER complementary DNA probe. In all animal passages the growth rate was significantly higher in estradiol-treated mice compared with the control. TAM alone had some growth stimulatory effect, but much smaller than observed in the estradiol group. TAM inhibited estradiol-stimulated growth. These results suggest that estradiol and possibly TAM are capable of stimulating tumor growth in the athymic mice independently from ER, potentially through a host-mediated mechanism.

¹ Supported by NIH Grant PO1 20432.

² Recipient of a scholarship from the "Deutsche Forschungsgemeinschaft."

³ Department of Human Oncology, University of Wisconsin Clinical Cancer Center, 600 Highland Avenue, Madison, WI 53792.

Received 10/24/88. Revised 2/27/89. Accepted 6/ 8/89.

This article has been cited by other articles:

				M. Takahashi, T. Shimomoto, K. Miyajima, S. Iizuka, T. Watanabe, M. Yoshida, Y. Kurokawa, and A. Maekawa Promotion, but not progression, effects of tamoxifen on uterine carcinogenesis in mice initiated with N-ethyl-N'-nitro-N-nitrosoguanidine Carcinogenesis, September 1, 2002; 23(9): 1549 - 1555. [Abstract] [Full Text] [PDF]